Driven by evidence
Backed with a guarantee
Blood culture results you can trust
Newly Released: Cost-Benefit Analysis of Steripath
A University of Houston study concludes hospitals can save up to $367 per blood culture after adopting Steripath.
A Partnership Inspired by Evidence
We are pleased to announce our partnership with the Center for Phlebotomy Education. Discover new evidence-based education, training and earn CEU credit.
Partnering with you to eliminate blood culture contamination
The Steripath® Gen2 Initial Specimen Diversion Device (ISDD®) has been clinically proven to virtually eliminate preventable blood culture contamination and false-positive results for bloodstream infections and sepsis.
Clinically Proven, Guaranteed Results.
Lee Health Improves Sepsis Testing Accuracy
Lee Health clinicians reported an 83% reduction in false positive diagnostic results for bloodstream infections like sepsis, following the adoption of Steripath across the health system’s four emergency departments.
UNMC Clinical Trials
Used by reputable hospitals around the country and proven in countless clinical trials– Steripath has been clinically proven to sustain a blood culture rate of 0.2% and a reduction in false positives by 92%.
MUSC Health Achieves Unprecedented Results
The Medical University of South Carolina achieved a nearly four-fold decrease in contaminated blood cultures in their Emergency Department, sustained over 20 months. They discuss their experience with Steripath and the impact that improved sepsis diagnostic accuracy has on patient safety.